E3 Bio Babraham Research Campus, Babraham, Cambridge CB22 3AT

RxCelerate Ltd

RxCelerate is an out-sourced drug development platform, which can be provide a complete development service for any preclinical asset (whether small molecule or biologic) through to clinical proof-of-concept. RxCelerate specializes in non-clinical models of diseases, and offers a wide range of bespoke efficacy models, including a unique combination study design that combines efficacy and toxicology end-points in a single study wrapper.

Established in April 2012, RxCelerate has quickly acquired a diverse array of clients, ranging from virtual asset-centric biotech companies through to global pharmaceutical giants.